loader
Please Wait
Applying Filters...

Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2011_189___rev_04 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Fresenius Kabi Oncology Limited

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN (1)

    filter

    01 Docetaxel trihydrate (1)

    filter

    01 India (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    FRESENIUS KABI ONCOLOGY LIMITED Kal...

    Contact Supplier
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Docetaxel trihydrate

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2011-189 - Rev 04
    Valid
    Chemical
    2023-02-16
    2449
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2011-189 - Rev 04 of Fresenius Kabi Oncology Limited Kalyani In

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2011-189 - Rev 04 of Fresenius Kabi Oncology Limited Kalyani In 1

    20

    Fresenius Kabi Oncology Limited Kalyani In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.

    One of their significant offerings is Docetaxel trihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2011-189 - Rev 04

    This Chemical Type CEP, issued on February 16, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2449 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY